"Technologie zna\u010Den\u00ED lyofilizovan\u00FDch konjug\u00E1t\u016F protil\u00E1tky s bifunk\u010Dn\u00EDm chel\u00E1torem isothiokyan\u00E1tobenzyl-DTPA radionuklidem 177Lu" . . "Kronr\u00E1d, Leo" . . . "Angelis, Bohumil" . . "Technology of labelling of lyophylised conjugates of monoclonal antibody with isothiocyanatobenzyl-DTPA by radionuclide 177Lu"@en . . . "Technologie zna\u010Den\u00ED lyofilizovan\u00FDch konjug\u00E1t\u016F protil\u00E1tky s bifunk\u010Dn\u00EDm chel\u00E1torem isothiokyan\u00E1tobenzyl-DTPA radionuklidem 177Lu"@cs . . . "RIV/46356088:_____/08:#0000773!RIV09-MSM-46356088" . . "[7EE63C3B1EC5]" . "Technologie umo\u017E\u0148uj\u00EDc\u00ED zna\u010Den\u00ED lyofilizovan\u00FDch protil\u00E1tek" . . . "Vyu\u017Eit\u00ED v dal\u0161\u00EDm v\u00FDzkumu l\u00E9\u010Div" . "Labelling; Monoclonal antibody"@en . "Conjugates of monoclonal antibody MEM-97 with isothiocyanatobenzyl-DTPA were prepared by mixing both compounds and let to react 24 hours at room temperature. Excess of the chelating agens was separated by centrifugation in centrifugal separator Vivaspin. The pure resulted product was lyophilised under the same conditions like other medicinal preparations produced in NRI. The conjugates were labelled by radionuclide 177Lu and the product purified using cenrifugal separator Vivaspin."@en . . "399285" . "Technologie zna\u010Den\u00ED lyofilizovan\u00FDch konjug\u00E1t\u016F protil\u00E1tky s bifunk\u010Dn\u00EDm chel\u00E1torem isothiokyan\u00E1tobenzyl-DTPA radionuklidem 177Lu" . . . . "2"^^ . "RIV/46356088:_____/08:#0000773" . "Technology of labelling of lyophylised conjugates of monoclonal antibody with isothiocyanatobenzyl-DTPA by radionuclide 177Lu"@en . "Centrum v\u00FDzkumu \u0158e\u017E s.r.o" . . "MEM97-ITKBDTPA-177Lu" . "Technologie zna\u010Den\u00ED lyofilizovan\u00FDch konjug\u00E1t\u016F protil\u00E1tky s bifunk\u010Dn\u00EDm chel\u00E1torem isothiokyan\u00E1tobenzyl-DTPA radionuklidem 177Lu"@cs . "Konjug\u00E1ty monoklon\u00E1ln\u00ED protil\u00E1tky MEM-97 anti CD20 s isothiokyanatobenzyl-DTPA byly p\u0159ipraveny sm\u00EDch\u00E1n\u00EDm obou slo\u017Eek a ponech\u00E1ny reagovat po dobu 24 nod p\u0159i pokojov\u00E9 teplot\u011B. P\u0159ebytek chelata\u010Dn\u00EDho \u010Dinidla byl separov\u00E1n centrifugac\u00ED pomoc\u00ED cetrifuga\u010Dn\u00EDho separ\u00E1toru Vivaspin. Z\u00EDskan\u00FD produkt byl lyofilizov\u00E1n za stejn\u00FDch podm\u00EDnek jako b\u011B\u017En\u00E9 p\u0159\u00EDpravky vyr\u00E1b\u011Bn\u00E9 pro l\u00E9ka\u0159sk\u00E9 \u00FA\u010Dely vyr\u00E1b\u011Bn\u00E9 v \u00DAJV. Konjug\u00E1ty byly zna\u010Deny radionuklidem 177Lu a p\u0159e\u010Di\u0161t\u011Bny op\u011Bt za pou\u017Eit\u00ED centrifuga\u010Dn\u00EDho separ\u00E1toru Vivaspin." . "2"^^ . . . . . "Konjug\u00E1ty monoklon\u00E1ln\u00ED protil\u00E1tky MEM-97 anti CD20 s isothiokyanatobenzyl-DTPA byly p\u0159ipraveny sm\u00EDch\u00E1n\u00EDm obou slo\u017Eek a ponech\u00E1ny reagovat po dobu 24 nod p\u0159i pokojov\u00E9 teplot\u011B. P\u0159ebytek chelata\u010Dn\u00EDho \u010Dinidla byl separov\u00E1n centrifugac\u00ED pomoc\u00ED cetrifuga\u010Dn\u00EDho separ\u00E1toru Vivaspin. Z\u00EDskan\u00FD produkt byl lyofilizov\u00E1n za stejn\u00FDch podm\u00EDnek jako b\u011B\u017En\u00E9 p\u0159\u00EDpravky vyr\u00E1b\u011Bn\u00E9 pro l\u00E9ka\u0159sk\u00E9 \u00FA\u010Dely vyr\u00E1b\u011Bn\u00E9 v \u00DAJV. Konjug\u00E1ty byly zna\u010Deny radionuklidem 177Lu a p\u0159e\u010Di\u0161t\u011Bny op\u011Bt za pou\u017Eit\u00ED centrifuga\u010Dn\u00EDho separ\u00E1toru Vivaspin."@cs . . "P(1M0505), Z(MSM2672244501)" .